IL-17 enhances chemokine gene expression through mRNA stabilization

Journal of Immunology

Volumn 179, Issue 6, 2007, Pages 4135-4141

  Hartupee, Justin ^a   Liu, Caini ^a   Novotny, Michael ^a   Li, Xiaoxia ^a   Hamilton, Thomas ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CXCL1 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; MESSENGER RNA; NUCLEIC ACID BINDING PROTEIN; PROTEIN ACT1; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACT1 PROTEIN, MOUSE; ALPHA CHEMOKINE; CXCL1 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA STABILITY; ANIMAL; BIOSYNTHESIS; CELL STRAIN 3T3; GENE EXPRESSION REGULATION; GENETICS; HALF LIFE TIME; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CHEMOKINES, CXC; GENE EXPRESSION REGULATION; HALF-LIFE; HELA CELLS; HUMANS; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; NF-KAPPA B; RNA STABILITY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35748973565     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.6.4135     Document Type: Article

References (42)

1. Weaver, C. T., L. E. Harrington, P. R. Mangan, M. Gavrieli, and K. M. Murphy. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
2. McKenzie, B. S., R. A. Kastelein, and D. J. Cua. 2006. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27: 17-23.
3. Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, et al. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603.
4. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527.
5. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
6. Shen, F., M. J. Ruddy, P. Plamondon, and S. L. Gaffen. 2005. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-α-induced genes in bone cells. J. Leukocyte Biol. 77: 388-399.
7. Awane, M., P. G. Andres, D. J. Li, and H. C. Reinecker. 1999. NF-κB-inducing kinase is a common mediator of IL-17-, TNF-α-, and IL-1 β-induced chemokine promoter activation in intestinal epithelial cells. J. Immunol. 162: 5337-5344.
8. Shalom-Barak, T., J. Quach, and M. Lotz. 1998. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB. J. Biol. Chem. 273: 27467-27473.
9. Faour, W. H., A. Mancini, Q. W. He, and J. A. Di Battista. 2003. T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3′-untranslated region of COX-2 mRNA. J. Biol. Chem. 278: 26897-26907.
10. Yamazaki, S., T. Muta, S. Matsuo, and K. Takeshige. 2005. Stimulus-specific induction of a novel nuclear factor-κB regulator, IκB-ζ, via Toll/interleukin-1 receptor is mediated by mRNA stabilization. J. Biol. Chem. 280: 1678-1687.
11. Henness, S., E. van Thoor, Q. Ge, C. L. Armour, J. M. Hughes, and A. J. Ammit. 2006. IL-17A acts via p38 MAPK to increase stability of TNF-α-induced IL-8 mRNA in human ASM. Am. J. Physiol. 290: L1283-L1290.
12. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83: 1670-1674.
13. Chen, C. Y., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20: 465-470.
14. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667.
15. Saklatvala, J., J. Dean, and A. Clark. 2003. Control of the expression of inflammatory response genes. Biochem. Soc. Symp. 70: 95-106.
16. Holtmann, H., R. Winzen, P. Holland, S. Eickemeier, E. Hoffmann, D. Wallach, N. L. Malinin, J. A. Cooper, K. Resch, and M. Kracht. 1999. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol. Cell. Biol. 19: 6742-6753.
17. Carballo, E., W. S. Lai, and P. J. Blackshear. 1998. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281: 1001-1005.
18. Kontoyiannis, D., M. Pasparakis, T. T. Pizarro, F. Cominelli, and G. Kollias. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387-398.
19. Taylor, G. A., E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson, D. D. Patel, D. I. Schenkman, G. S. Gilkeson, H. E. Broxmeyer, B. F. Haynes, and P. J. Blackshear. 1996. A pathogenetic role for TNF α in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4: 445-454.
20. Stoeckle, M. Y. 1991. Post-transcriptional regulation of groα, β, γ-, and IL-8 mRNAs by IL-1β. Nucleic Acids Res. 19: 917-920.
21. Tebo, J., S. Datta, R. Kishore, M. Kolosov, J. A. Major, Y. Ohmori, and T. A. Hamilton. 2000. IL-1-mediated stabilization of mouse KC mRNA depends on sequences in both 5′ and 3′ untranslated regions. J. Biol. Chem. 275: 12987-12993.
22. Biswas, R., S. Datta, J. D. Gupta, M. Novotny, J. Tebo, and T. A. Hamilton. 2003. Regulation of chemokine mRNA stability by lipopolysaccharide and IL-10. J. Immunol. 170: 6202-6208.
23. Dean, J. L., M. Brook, A. R. Clark, and J. Saklatvala. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274: 264-269.
24. Ohmori, Y., S. Fukumoto, and T. A. Hamilton. 1995. Two structurally distinct κB sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages. J. Immunol. 155: 3593-3600.
25. Ohmori, Y., and T. A. Hamilton. 1994. Cell type and stimulus specific regulation of chemokine gene expression. Biochem. Biophys. Res. Commun. 2: 590-596.
26. Qian, Y., C. Liu, J. Hartupee, C. Altuntas, M. F. Gulen, D. Jane-wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256.
27. Novotny, M., S. Datta, R. Biswas, and T. Hamilton. 2005. Functionally independent AU-rich sequence motifs regulate KC (CXCL1) mRNA. J. Biol. Chem. 280: 30166-30174.
28. Datta, S., M. Novotny, X. Li, J. Tebo, and T. A. Hamilton. 2004. Toll IL-1 receptors differ in their ability to promote the stabilization of adenosine and uridine-rich elements containing mRNA. J. Immunol. 173: 2755-2761.
29. Armstrong, D. A., J. A. Major, A. Chudyk, and T. A. Hamilton. 2004. Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J. Leukocyte Biol. 75: 641-648.
30. Introna, M., R. C. Bast, Jr., C. S. Tannenbaum, T. A. Hamilton, and D. O. Adams. 1987. The effect of LPS on expression of the early " competence" genes JE and KC in murine peritoneal macrophages. J. Immunol. 11: 3891-3896.
31. Dai, Y., S. Datta, M. Novotny, and T. A. Hamilton. 2003. TGFβ inhibits LPS-induced chemokine mRNA stabilization. Blood 102: 1178-1185.
32. Li, X., M. Commane, H. Nie, X. Hua, M. Chatterjee-Kishore, D. Wald, M. Haag, and G. R. Stark. 2000. Act1, an NF-κB-activating protein. Proc. Natl. Acad. Sci. USA 97: 10489-10493.
33. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274: 787-789.
34. Ohmori, Y., S. Fukumoto, and T. A. Hamilton. 1995. Two structurally distinct κB sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages. J. Immunol. 155: 3593-3600.
35. Hata, K., A. Andoh, M. Shimada, S. Fujino, S. Bamba, Y. Araki, T. Okuno, Y. Fujiyama, and T. Bamba. 2002. IL-17 stimulates inflammatory responses via NF-κB and MAP kinase pathways in human colonic myofibroblasts. Am. J. Physiol. 282: G1035-G1044.
36. Rahman, M. S., J. Yang, L. Y. Shan, H. Unruh, X. Yang, A. J. Halayko, and A. S. Gounni. 2005. IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanism. Clin. Immunol. 115: 268-276.
37. Shimada, M., A. Andoh, K. Hata, K. Tasaki, Y. Araki, Y. Fujiyama, and T. Bamba. 2002. IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators. J. Immunol. 168: 861-868.
38. Wuyts, W. A., B. M. Vanaudenaerde, L. J. DuPont, D. E. Van Raemdonck, M. G. Demedts, and G. M. Verleden. 2005. Interleukin-17-induced interleukin-8 release in human airway smooth muscle cells: role for mitogen-activated kinases and nuclear factor-κB. J. Heart Lung Transplant. 24: 875-881.
39. Chang, S. H., H. Park, and C. Dong. 2006. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281: 35603-35607.
40. Clark, A. R., J. L. Dean, and J. Saklatvala. 2003. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett. 546: 37-44.
41. Winzen, R., M. Kracht, B. Ritter, A. Wilhelm, C. Y. Chen, A. B. Shyu, M. Muller, M. Gaestel, K. Resch, and H. Holtmann. 1999. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18: 4969-4980.
42. Holtmann, H., J. Enninga, S. Kalble, A. Thiefes, A. Dorrie, M. Broemer, R. Winzen, A. Wilhelm, J. Ninomiya-Tsuji, K. Matsumoto, et al. 2001. The MAPK kinase kinase TAK1 plays a central role in coupling the interleukin-1 receptor to both transcriptional and RNA-targeted mechanisms of gene regulation. J. Biol. Chem. 276: 3508-3516.